ArticleSocial science & medicine (1982)2025
US-born and foreign-born life expectancy by race and Hispanic origin before and during the COVID-19 pandemic in the United States.
Article in Social science & medicine (1982), 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
4 citing papers in PubMed.
- Rising Black life expectancy in an era of increased immigration.American journal of epidemiology · 2026Article
- The Latino health experience: Past and future.Proceedings of the National Academy of Sciences of the United States of America · 2026Article
- The role of social determinants in COVID-19 hospitalization disparities by migration status in Stockholm, Sweden. A population-based cohort study.Communications medicine · 2026Article
- Fragile gains: The impact of refugees and other permit immigrants on national life expectancy in Sweden before, during, and after the COVID-19 pandemic.Journal of migration and health · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
2 authors.
Funding
Abstract
Interdisciplinary health scholarship has long documented the lower mortality of the foreign-born compared to the US-born populations. In this study, we examine the impact of the COVID-19 pandemic on this migrant mortality advantage in 2020, 2021 and 2022 compared to 2017-2019 and estimate the contributions of the foreign-born population to US life expectancy by race and Hispanic Origin. In 2020, life expectancy declined more among all foreign-born subgroups than their US-born counterparts. The overall foreign-born life expectancy advantage declined by 1.0 year for women by 2.4 years for men and their contribution to US life expectancy declined by 0.13 years for women and 0.30 years for men. In 2021, mortality continued to increase among all US-born subgroups, but it declined among all foreign-born populations and their contributions to US life expectancy recovered their pre-pandemic size for women, but not for men. In 2022, both US-born and foreign-born life expectancies increased and the foreign-born contribution to US life expectancy exceeded its pre-pandemic size for women but not for men. At the same time, however, life expectancies for US-born and foreign-born men and women in 2022 remained below their level in 2017-2019. Among the foreign-born subgroups, Hispanic men experienced both the largest decline in life expectancy between 2017 and 2019 and 2020 and the slowest recovery by 2022. Overall, the U.S. experienced one of the largest life expectancy declines among high-income countries. This decline would have been even larger without the life expectancy gains of the foreign-born population in 2021 and 2022.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.